Table 2.
Medication Regimens of Study Participants
| AT (N = 79)a | CG (N = 62)a | Test Statistic | P | |
|---|---|---|---|---|
| N (%) | N (%) | |||
| Antipsychotic medicationb | ||||
| First generation only (N) | 3 (4%) | 1 (2%) | X 2(1) = 0.54 | .46 |
| Second generation only (N) | 58 (73%) | 49 (79%) | X 2(1) = 2.79 | .095 |
| First and second generations (N) | 2 (3%) | 5 (8%) | X 2(1) = 2.25 | .13 |
| No antipsychotic (N) | 16 (20%) | 7 (11%) | X 2(1) = 2.04 | 0.15 |
| Other psychiatric medication | ||||
| Antidepressants or mood stabilizers (N) | 27 (34%) | 23 (37%) | X 2(1) = 0.13 | .72 |
| Benzodiazepines (N) | 12 (15%) | 10 (16%) | X 2(1) = 0.023 | .88 |
| Other medication measures | ||||
| Chlorpromazine equivalentsc | 295.25 (290.82) | 369.94 (382.13) | t(114) = 1.194 | .24 |
| Changes in medication while in studyd | ||||
| Baseline—Post (N = 103) | 28 (52%) | 31 (63%) | X 2(1) = 1.37 | .24 |
| Post—Follow-up (N = 68) | 23 (66%) | 21 (64%) | X 2(1) = 0.032 | .86 |
Note: AT, auditory training group; CG, computer games control group.
aFour subjects missing medication data.
bFirst-generation antipsychotic medication = haloperidol, loxapine, perphenazine, thiothixene, and trifluoperazine. Second-generation antipsychotic medication = asenapine, aripiprazole, clozapine, iloperidone, lurasidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone.
cMean and SD of Chlorpromazine Equivalents.19
dChange in medication type, class, or dose.